NCT02507583 2025-05-07Antisense102: Pilot Immunotherapy for Newly Diagnosed Malignant GliomaThomas Jefferson UniversityPhase 1 Completed33 enrolled
NCT00805376 2018-07-16DNX-2401 (Formerly Known as Delta-24-RGD-4C) for Recurrent Malignant GliomasDNAtrix, Inc.Phase 1 Completed37 enrolled
NCT01644955 2018-07-02Carboplatin in Treating Patients With Recurrent High-Grade GliomasOhio State University Comprehensive Cancer CenterPhase 1 Completed10 enrolled